B. Kolukisa Et Al. , "Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency," Allergy: European Journal of Allergy and Clinical Immunology , vol.77, no.3, pp.1004-1019, 2022
Kolukisa, B. Et Al. 2022. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency. Allergy: European Journal of Allergy and Clinical Immunology , vol.77, no.3 , 1004-1019.
Kolukisa, B., Baser, D., Akcam, B., Danielson, J., Bilgic Eltan, S., Haliloglu, Y., ... Sefer, A. P.(2022). Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency. Allergy: European Journal of Allergy and Clinical Immunology , vol.77, no.3, 1004-1019.
Kolukisa, Burcu Et Al. "Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency," Allergy: European Journal of Allergy and Clinical Immunology , vol.77, no.3, 1004-1019, 2022
Kolukisa, Burcu Et Al. "Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency." Allergy: European Journal of Allergy and Clinical Immunology , vol.77, no.3, pp.1004-1019, 2022
Kolukisa, B. Et Al. (2022) . "Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency." Allergy: European Journal of Allergy and Clinical Immunology , vol.77, no.3, pp.1004-1019.
@article{article, author={Burcu Kolukisa Et Al. }, title={Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency}, journal={Allergy: European Journal of Allergy and Clinical Immunology}, year=2022, pages={1004-1019} }